BACKGROUND AND PURPOSE: We present early experience with the EKOS MicroLysUS
infusion catheter for acute embolic stroke treatment in North America. This study was …

Background Previous studies have suggested that desmoteplase, a novel plasminogen
activator, has clinical benefit when given 3–9 h after the onset of the symptoms of stroke in …

Background and Purpose—In the United States, tissue plasminogen activator (tPA) was
approved for treatment of acute ischemic stroke in 1996. Its use has only recently been …

Among 407 New England Medical Center Posterior Circulation registry patients, 59% had
strokes without transient ischemic attacks (TIAs), 24% had TIAs then strokes, and 16% had …

Background Atrial fibrillation is a leading preventable cause of recurrent stroke for which
early detection and treatment are critical. However, paroxysmal atrial fibrillation is often …

A young woman had sudden onset of a left hemiparesis. Initial studies showed a right
internal carotid artery (ICA) thrombus and reduced flow in the right middle cerebral artery (MCA). …

At last there is now more than 1 oral anticoagulant (OAC) available for stroke prevention in
atrial fibrillation. Though more choice is a good thing, it does mandate knowing which drug is …

… Cinnamon Teal consumed more animal than plant foods (… Animal food consumption was
greatest in Cinnamon Teal … diets of migrating Cinnamon Teal in dominant plant zones in …

Heat transfer and water vapor transport measurements performed at three laboratories using
the sweating guarded hot plate apparatus were standardized based on the International …

… “The needs for [unmanned aerial vehicles] are unsatisfied,” said Phil Finnegan, Teal
Group’s director of corporate analysis. “The military wants a lot more. Worldwide you have very …